StockData
Pfizer Inc logo

Pfizer Inc

PFENYSEPharmaceutical PreparationsFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 28, 2026Last filing: 10-Q on Aug 4, 2026Score 11/3053% above fair value
$30.67+0.15 (+0.49%)

Close on Nov 2, 2026Market cap $174.81BP/E 40.4Yield 5.61%

Pfizer Accrued interest & penalties on unrecognized tax by Year

Accrued interest & penalties on unrecognized tax benefits ($M) ($M)

Pfizer Accrued interest & penalties on unrecognized tax: $681M in FY2025, up 7.1% from a year earlier.

Latest, FY2025
681
Period ended Dec 31, 2025
Change on a year earlier
+7.1%
636 in FY2024
History
11 years
Since FY2015
Sources
10
Documents cited below

Where the FY2025 figure comes from

Source: Form 10-K (filed 2026-02-26) ↗

Reported in Form 10-Q / 10-K Taxes on Income Footnote.

Annual history

Hover a value to see the sentence it was read from; calculated values show their formula

PeriodEndedAccrued interest & penalties on unrecognized tax benefits ($M) ($M)Year on yearSource
FY2025Dec 31, 2025681+7.1%Form 10-K (filed 2026-02-26) ↗
FY2024Dec 31, 2024636+5.1%Form 10-K (filed 2026-02-26) ↗
FY2023Dec 31, 2023605+9.6%Form 10-K (filed 2025-02-27) ↗
FY2022Dec 31, 2022552-8.2%Form 10-K (filed 2024-02-22) ↗
FY2021Dec 31, 2021601+21.9%Form 10-K (filed 2023-02-23) ↗
FY2020Dec 31, 2020493+1.6%Form 10-K (filed 2022-02-24) ↗
FY2019Dec 31, 2019485-55.9%Form 10-K (filed 2021-02-25) ↗
FY2018Dec 31, 20181,100+12.8%Form 10-K (filed 2020-02-27) ↗
FY2017Dec 31, 2017975+26.5%Form 10-K (filed 2019-02-28) ↗
FY2016Dec 31, 2016771+8.0%Form 10-K (filed 2018-02-22) ↗
FY2015Dec 31, 2015714–Form 10-K (filed 2017-02-23) ↗

Cite this data

StockData. (2026). Pfizer Accrued interest & penalties on unrecognized tax ($M), annual FY2015–FY2025 [Data set]. Compiled from Pfizer SEC filings and investor materials. https://stockdatahq.com/stocks/pfe/kpis/utb-int-bal

See every metric in the Pfizer KPI table. Data updated Nov 2, 2026.